How to buy Radius Health stock - 18 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Radius Health stock

Own Radius Health stock in just a few minutes.

Radius Health, Inc is a drug manufacturers-specialty & generic business based in the US. Radius Health shares (RDUS) are listed on the NASDAQ and all prices are listed in US Dollars. Radius Health employs 310 staff and has a trailing 12-month revenue of around USD$238.6 million.

How to buy shares in Radius Health

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Radius Health. Find the stock by name or ticker symbol: RDUS. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Radius Health reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Radius Health, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Radius Health. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Radius Health share price

Use our graph to track the performance of RDUS stocks over time.

Radius Health shares at a glance

Information last updated 2021-04-16.
52-week rangeUSD$10.151 - USD$25.82
50-day moving average USD$21.0649
200-day moving average USD$17.9601
Wall St. target priceUSD$24.29
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-3.7

Buy Radius Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Radius Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Radius Health financials

Revenue TTM USD$238.6 million
Gross profit TTM USD$222.2 million
Return on assets TTM -25.08%
Return on equity TTM 0%
Profit margin -45.76%
Book value $-0.003
Market capitalisation USD$899 million

TTM: trailing 12 months

Shorting Radius Health shares

There are currently 5.7 million Radius Health shares held short by investors – that's known as Radius Health's "short interest". This figure is 0.7% down from 5.8 million last month.

There are a few different ways that this level of interest in shorting Radius Health shares can be evaluated.

Radius Health's "short interest ratio" (SIR)

Radius Health's "short interest ratio" (SIR) is the quantity of Radius Health shares currently shorted divided by the average quantity of Radius Health shares traded daily (recently around 611596.46680942). Radius Health's SIR currently stands at 9.34. In other words for every 100,000 Radius Health shares traded daily on the market, roughly 9340 shares are currently held short.

However Radius Health's short interest can also be evaluated against the total number of Radius Health shares, or, against the total number of tradable Radius Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Radius Health's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Radius Health shares in existence, roughly 120 shares are currently held short) or 0.1676% of the tradable shares (for every 100,000 tradable Radius Health shares, roughly 168 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Radius Health.

Find out more about how you can short Radius Health stock.

Radius Health share dividends

We're not expecting Radius Health to pay a dividend over the next 12 months.

Have Radius Health's shares ever split?

Radius Health's shares were split on a 1:2 basis on 23 April 2014. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Radius Health shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Radius Health shares which in turn could have impacted Radius Health's share price.

Radius Health share price volatility

Over the last 12 months, Radius Health's shares have ranged in value from as little as $10.151 up to $25.82. A popular way to gauge a stock's volatility is its "beta".

RDUS.US volatility(beta: 0.95)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Radius Health's is 0.9465. This would suggest that Radius Health's shares are less volatile than average (for this exchange).

Radius Health overview

Radius Health, Inc. , a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd. ; and Duke University.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site